Related Experiment Video
Updated: Oct 20, 2025

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using
Li Tai Fang1, Bin Zhu2, Yongmei Zhao3
1Bioinformatics Research & Early Development, Roche Sequencing Solutions Inc., Belmont, CA, USA.
Generating standardized DNA datasets is crucial for cancer genomics. This study provides reference call sets from a breast cancer cell line and lymphoblastoid cells to benchmark sequencing pipelines and algorithms.
Area of Science:
- Genomics
- Bioinformatics
- Cancer Research
Background:
- Limited availability of standardized DNA datasets hinders the implementation and adoption of cancer genomics.
- Establishing reliable sequencing pipelines and benchmarking algorithms requires high-quality reference data.
Purpose of the Study:
- To generate and describe reference call sets from paired tumor-normal genomic DNA (gDNA) samples.
- To provide a resource for setting up sequencing pipelines and benchmarking bioinformatics algorithms for cancer genomics.
Main Methods:
- Utilized paired tumor-normal gDNA samples from a heterogeneous breast cancer cell line and a matched lymphoblastoid cell line.
- Generated reference call sets for somatic mutations and germline variants.
- Partially validated call sets using whole-exome sequencing (WES) across different platforms and high-coverage targeted sequencing.
Main Results:
- Reference call sets were obtained from a breast cancer cell line (heterogeneous, aneuploid, enriched in somatic alterations) and a matched lymphoblastoid cell line.
- Validation via WES and targeted sequencing confirmed somatic mutations and germline variants with high confidence across 82% of genomic regions.
- The gDNA reference samples, while not primary cancer cells, minimize biases in sequencing pipelines.
Conclusions:
- The developed reference call sets serve as a valuable resource for establishing and validating cancer genomics sequencing pipelines.
- These reference samples are essential for benchmarking both 'tumor-only' and 'matched tumor-normal' analysis strategies.
- The study addresses the critical need for standardized data in advancing cancer genomics research and clinical applications.
More Related Videos
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016